A DEA accountability audit is not a walk-through of the pharmacy's shelves. It is a computation: the investigator starts from a prior inventory, adds every unit purchased, subtracts every unit documented as dispensed, and compares that theoretical count to the physical count taken that day. Where the two numbers disagree, the file records a shortage and the pharmacy is asked to explain it. The computation rests on assumptions about dates, counts and documents that a registrant can test before the finding becomes a civil penalty demand or an order to show cause.
How a DEA Accountability Audit Is Built
The audit begins at the pharmacy's most recent 21 CFR 1304.11 inventory, the biennial count that fixes a starting quantity for each schedule. From there, the investigator adds units received, using DEA Form 222 or CSOS order records for Schedule II purchases and supplier invoices for Schedule III through V, and subtracts units the pharmacy's own records show as dispensed over the period reviewed. The result is a theoretical count, checked against a physical count of what is actually on the shelf during the visit. This differs from suspicious order monitoring, which flags an unusual purchase before it ships. An accountability audit instead reconstructs, after the fact, what should be on hand and measures the gap.
The Audit Period and the Counts at Each End
An investigator selects the audit period, and that choice is worth testing rather than accepting. A window that starts mid-month, spans a period with a supplier changeover, or runs longer because of a prior finding changes how many transactions have to reconcile correctly for the count to close. The beginning and ending figures matter just as much as the window: Schedule II counts must be exact under 1304.11, while Schedule III through V may be estimated except in containers of more than 1,000 dosage units. A beginning count carried forward from an old inventory that was itself estimated, rather than a verified exact count, can manufacture a shortage that never existed in the pharmacy's actual stock.
A shortage finding is only as reliable as the two counts and every transaction the audit assumed happened correctly in between.
Missing Invoices, Returns, Destructions and Transfers
Four categories of documents routinely explain an apparent shortage once they are produced. A purchase invoice dated just outside the audit window, or misfiled under the wrong date, drops a real receipt out of the theoretical count. Product returned to a wholesaler or manufacturer, and units destroyed and recorded on a DEA Form 41, both reduce what should be on hand, but only if the investigator's file actually contains them. Transfers between a registrant's own locations are the most commonly missed line: stock sent from one pharmacy to a sister location under common ownership has to be subtracted at the sending site and added at the receiving one, and a transfer recorded at only one end produces a shortage at the other that was never a loss.
Assembling the Reconciliation Before the Finding Hardens
A registrant's strongest position is a line-by-line reconciliation, matched invoice by invoice and transfer by transfer against the audit period the investigator used, presented before the finding is written up as final. Once a shortage is characterized as unexplained, recordkeeping failures alone can support a civil penalty under 21 U.S.C. 842(a), and a pattern read as diversion can support an order to show cause under 21 U.S.C. 824(a) or, in the most severe cases, an immediate suspension order. Registrants preparing for a DEA inspection should also see our companion pieces on a pharmacy's rights during a DEA inspection, responding to a DEA order to show cause, and building an audit-ready controlled substance file and a perpetual inventory system that keeps the next audit from starting with a stale count.
Why Early Legal Counsel Is Critical
It is critical that pharmacies retain experienced healthcare defense counsel promptly upon receiving notice of a DEA accountability audit or a preliminary shortage finding. Early legal intervention can protect the registrant's rights, ensure the inventory reconciliation presented to the investigator is complete and accurate, avoid inadvertent admissions in an informal explanation, and preserve defenses before the finding is finalized. Delaying legal representation can significantly affect the outcome and expose the registration to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance has represented 2,500+ clients over 25+ years, including pharmacies contesting DEA accountability audits before a shortage finding becomes a penalty demand. Our DEA defense attorneys rebuild reconciliations line by line, challenge the audit period and the counts an investigator relied on, and represent registrants once a civil penalty or an order to show cause is already in place. Contact Health Law Alliance for a free, confidential consultation.
